A major pharmaceutical company, based in Europe, faced a challenge in seeking approval of medicinal product containing controlled DS. RegPak BioPharma prepared the dossier for the Agency dealing with Controlled Drugs to seek approval prior to gaining regulatory approval. The work was delivered within a short time to the client, following which the responsibility of MAA submission was given to RegPak BioPharma.